Literature DB >> 2293567

An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence.

S P Stowe1, S R Redmond, J M Stormont, A N Shah, L N Chessin, H L Segal, W Y Chey.   

Abstract

The epidemiological understanding of inflammatory bowel disease has been limited by the referral bases of most inflammatory bowel disease studies. The Colitis-Ileitis Study Group of Rochester, N.Y., developed a community-wide, computerized cumulative registry of all inflammatory bowel disease patients hospitalized at the 8 community hospitals for 1973-86. Clinical data were abstracted from each of the 1651 identified hospital charts. All of these patients resided in Monroe County (city and suburbs) and the 5 contiguous counties (Genesee/Finger Lakes Region, population 1,030,640). Of the 1651 hospital patients identified in the study, 1358 resided in Monroe County (Rochester and its immediate suburbs, population 702,238). Incidence, defined as time of onset of symptoms of inflammatory bowel disease, rose from baseline rates in the 1930s to peak in 1980 (Crohn's disease = 50.29/10(5) per decade, ulcerative colitis = 35.12/10(5) per decade) and declined through 1986. For Crohn's disease, the age-specific incidence rates peaked in the 20-29-yr-old group in each of the 5 decades studied. Ulcerative colitis seems to occur at all ages and may have a bimodal distribution. There was a period effect, with the 1970s having the highest incidence of Crohn's disease and ulcerative colitis for each age group. However, the age-specific incidence rate for Crohn's disease showed a 40% decrease in the 1980s compared with the 1970s in the 10-39-yr-old group (p less than 0.001). The age-specific incidence rate for ulcerative colitis showed a 50% decrease in the 1980s compared with the 1970s in the 10-49-yr-old group (p less than 0.001).

Entities:  

Mesh:

Year:  1990        PMID: 2293567     DOI: 10.1016/0016-5085(90)91297-j

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  33 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Authors:  Laszlo Lakatos; Gabor Mester; Zsuzsanna Erdelyi; Mihaly Balogh; Istvan Szipocs; Gyorgy Kamaras; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

3.  Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

Authors:  J A Eaden; J F Mayberry
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  Crohn's disease in Bangladeshis and Europeans in Britain: an epidemiological comparison in Tower Hamlets.

Authors:  C S Probert; V Jayanthi; D J Pollock; S I Baithun; J F Mayberry; D S Rampton
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

5.  Association of age at diagnosis and ulcerative colitis phenotype.

Authors:  Sandra M Quezada; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2012-02-28       Impact factor: 3.199

6.  A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.

Authors:  Leslie M Higuchi; Hamed Khalili; Andrew T Chan; James M Richter; Athos Bousvaros; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

Review 7.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 8.  Cost of illness of Crohn's disease.

Authors:  Keith Bodger
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 9.  Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children.

Authors:  Theresa A Mikhailov; Sylvia E Furner
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

10.  Development and validation of an administrative case definition for inflammatory bowel diseases.

Authors:  Ali Rezaie; Hude Quan; Richard N Fedorak; Remo Panaccione; Robert J Hilsden
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.